Chimeric antigen receptor T-cell therapy for relapsed and refractory large B-cell lymphoma: A Canadian perspective. Can Hematol Today [Internet]. 2022 Jul. 1 [cited 2026 Oct. 22];1(2):22–29. Available from: https://canadianhematologytoday.com/article/view/1-2-4-elsawy